Shanghai Renji Hospital
Shanghai Renji Hospital
Shanghai, Shanghai Municipality, China2 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Cadonilimab (AK104) Plus Lenvatinib in Previously Immunotherapy-Treated Advanced/Metastatic Clear Cell Renal Cell Carcinoma | Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, Neoplasms by Histologic Type, Neoplasms by Site, Urogenital Diseases, Urogenital Neoplasms, adenocarcinoma, benign urinary system neoplasm, carcinoma, clear cell renal carcinoma, epithelial neoplasm, kidney cancer, kidney disorder, neoplasm, renal cell carcinoma, urinary system disorder | Active, not recruiting | Phase 2 | 2026-05-19 | NCT06035224 | |
| Prognosis of Patients With Upper Tract Urothelial Carcinoma Receiving Kidney-sparing Therapy | Upper Tract Urothelial Carcinoma Receiving Kidney-sparing Therapy | Recruiting | Not stated | 2024-01-12 | NCT06204406 |